Cite
HARVARD Citation
Gronich, N. et al. (2022). Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real‐Life: Retrospective Cohort Study. Clinical pharmacology & therapeutics. 111 (5), pp. 1084-1092. [Online].